$44.66
+1.02%
N/A+$0.45
Healthcare
Drug Manufacturers - General
NASDAQ
Active Trading
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic ...
C-Suite Executives
(0)The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.
Key Team Members
No executives available for this level
Loading executive datasets...
Founder / CEO
1
C-Level
7
VP
0
Board
0
Director / Board
3
Other
0
Key Executives
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Belen Garijo Lopez | Chief Executive Officer & Director | EUR 4,724,298 | 1960 | Active | |
| Thomas Triomphe | Executive Vice President of Vaccines | — | 1974 | Active | |
| Olivier Charmeil | Executive Vice President of General Medicines | — | 1963 | Active | |
| Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing | — | 1957 | Active | |
| Roy Papatheodorou | Executive Vice President & General Counsel | — | 1978 | Active | |
| Thomas Kudsk Larsen | Head of Investor Relations & General Medicines | — | 1974 | Active | |
| Madeleine Roach | Executive Vice President & Head of Business Operations | — | 1984 | Active | |
| Natalie Bickford | Executive Vice President & Chief People Officer | — | 1970 | Active | |
| Fabrizio Gaudi | Head of Austrian, German & Swiss Operations | — | — | — | Active |
| Erik Wallström | Head of Therapeutic Area - Neurology Development | — | — | Active | |
| François-Xavier Roger | Executive Vice President & Chief Financial Officer | — | 1962 | Active |
Executive Compensation
(deduped by latest filing date per person-year)| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|
Total Compensation Trend
Sum of disclosed compensation by year (USD million)
Key Roles Compensation Lines
Top founder/C-level executives over time (USD million)